Glucocorticoid hormone, aging brain and dementia

Functional Neurology

Volumn 12, Issue 3-4, 1997, Pages 167-173

  Angelucci, Luciano ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Aging; Brain; Dementia; Glucorticoid hormone

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR;

ANIMAL; ARTICLE; BRAIN; CELL AGING; DEMENTIA; HIPPOCAMPUS; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NERVE CELL INHIBITION; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT;

ANIMALS; BRAIN; CELL AGING; DEMENTIA; GLUCOCORTICOIDS; HIPPOCAMPUS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEURAL INHIBITION; PITUITARY-ADRENAL SYSTEM; RATS; RECEPTORS, GLUCOCORTICOID;

EID: 0031134075     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Landfield P, Baskin R, Piller T. Brain-aging correlates: retardation by hormonal-pharmacological treatments. Science 1981;214: 581-584
2. Angelucci L, Valeri P, Grossi E, Veldhuis H, Bohus B, de Kloet E. Involvement of hippocampal corticosterone receptors in behavioral phenomena. In: Brambilla F, Racagni G, de Wied E eds Progress in Psy-choneuroendocrinology. Amsterdam: Elsevier: 1980;177-185
3. Sapolsky RM. Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress 1996;1:1-19
4. Oxenkrug GF, Pomara N, McIntyre I et al. Aging and cortisol resistance to suppression by dexamethasone: a positive correlation. Psychiatry Res 1983;10:125-130
5. De Leon M, McRae T, Tsai J et al. Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet 1988;2:391-392
6. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 1986;7:284-301
7. Sapolsky RM, Krey LC, McEwen BS. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J. Neurosci 1985;5:1222-1227
8. Sapolsky RM. Why stress is bad for your brain. Science 1996;273:749-750
9. Sapolsky RM, Pulsinelli WA. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 1985;229: 1397-1400
10. Scaccianoce S, Alemà GS, Cigliana G, Nicolai R, Buttarelli FR, Angelucci L. Neurotoxicity of kainate to the hippocampus is not accrued by aging, stress and exogenous corticosterone in Wistar Kyoto and spontaneously hypertensive rats. Stress 1997 (in press)
11. Oitzl MS, van Haarst AD, Sutanto W, de Kloet ER. Corticosterone, brain mineralocorticoid receptor (MRs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: the Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinology 1995;20:655-675
12. Patchev VK, Kalogeras KT, Zelazowski P, Wilder RL. Chrousos GP. Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats. Endocrinology 1992;131:1453-1457
13. Gertz BJ, Contreras LN, McComb DJ, Kovacs K, Tyrell JB, Dallman MF. Chronic administration of corticotropin-releasing factor increases pituitary corticotroph number. Endocrinology 1987;120:381-388
14. Sternberg EM, Hill JM, Chrousos GP et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 1989;86:2374-2378
15. Griffin AC, Whitacre CC. Sex and strain differences in the circadian rhythm fluctuation of endocrine and immune function in the rat: implications for rodent models of autoimmune disease. J Neuroimmunol 1991; 35:53-64
16. Klug TL, Adelman RC. Altered hypothalamic-pituitary regulation of thyrotropin in male rats during aging. Endocrinology 1979;104:1136-1142
17. Dimond DM, Bennett MC, Fleshner M, Rose GM. Inverted U-relationship between the level of peripheral corticosterone and the magnitude of hippocampal primed burst potentiation. Hippocampus 1992;2:421-430
18. Bohus B, De Kloet ER. Adrenal steroids and extinction behavior: antagonism by progesterone, deoxycorticosterone and dexamethasone of a specific effect of corticosterone. Life Sci 1981;28:443-440
19. Landfield PW, Eldridge JC. Increased affinity of type II corticosteroid binding in aged rat hippocampus. Exp Neurol 1989; 106:110-113
20. Eldrige JC, Brodish A, Kute TE, Landfield PW. Apparent age-related resistance of type II hippocampal corticosteroid receptors to down-regulation during chronic escape training. J Neurosci 1989;9:3237-3242
21. Luine V, Martinez C, Villegas M, Magarinos AM, McEwen BS. Restraint stress reversibly enhances spatial memory performance. Physiol Behav 1996;59:27-32
22. Nichols NR, Finch CE. Gene products of corticosteroid action in hippocampus. Ann NY Acad Sci 1994;746:145-154
23. Bryan RM Jr. Cerebral blood flow and energy metabolism during stress. Am J Physiol 1990;259:H269-H280
24. Scaccianoce S, Di Sciullo A, Angelucci L. Age-related changes in hypothalamo-pituitary-adrenocortical axis activity in the rat. Neuroendocrinology 1990;52:150-155
25. Scaccianoce S, Nicolai R, Cigliana G, Angelucci L. Reduced glucocorticoid response to corticotropin secretagogues in the aged Sprague-Dawley rat. Neuroendocrinology 1995;62:32-38
26. Fliers E, Swaab DF. Activation of vasopressinergic and oxytocinergic neurons during aging in the Wistar rat. Peptides 1983;4:165-170
27. Miller M. Increased vasopressin secretion: an early manifestation of aging in the rat. J Gerontol 1987;42:3-7
28. Scaccianoce S, Muscolo LAA, Cigliana G, Navarra D, Nicolai R, Angelucci L. Evidence for a specific role of vasopressin in sustaining pituitary-adrenocortical stress response in the rat. Endocrinology 1991; 128:3138-3143
29. Swaab DF, Raadsheer FC, Endert E, Hofman MA, Kamphorst W, Ravid R. Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid. J Neuroendocrinol 1994;6:681-687
30. Raadsheer FC, Oorschot DE, Verwer RWH, Tilders FJH, Swaab DF. Age related increase in the total number of corticotropin-releasing hormone neurons in the human paraventricular nucleus in controls and Alzheimer's disease: comparison of the di- sector with an unfolding method. J. Comp Neurol 1994;339:447-457
31. Raadsheer FC, Tilders FJH, Swaab DF. Similar age related increase of vasopressin colocalization in paraventricular corticotropin-releasing hormone neurons in controls and Alzheimer patients. J Neuroendocrinol 1994;6:131-133
32. Raadsheer FC, Van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJH, Swaab DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease or depression. Am J Psychiatry 1995;152: 1372-1376
33. Nasman B, Olsson T, Seckl JR et al. Abnormalities in adrenal androgens, but not of glucocorticoids, in early Alzheimer's disease. Psychoneuroendocrinology 1994;20:83-94
34. Plihal W, Krug R, Pietrowsky R, Fehm HL, Born J. Corticosteroid receptor mediated effects on mood in humans. Psychoneuroendocrinology 1996;21:515-523